Literature DB >> 9852971

Isolation and utilization of human dendritic cells from peripheral blood to assay an in vitro primary immune response to varicella-zoster virus peptides.

D E Jenkins1, L L Yasukawa, C J Benike, E G Engleman, A M Arvin.   

Abstract

A human dendritic cell-based assay used to monitor a T cell proliferation response to viral peptides in vitro is described. Dendritic cells and autologous CD4+ T cells were isolated from peripheral blood by a series of density-gradient centrifugations or magnetic bead separations (or both). Peptides corresponding to residues of the immediate early protein, IE62, of varicella-zoster virus (VZV) were used as stimulating antigens, and persons with no history of varicella and no humoral or cellular immunity to VZV served as naive donors for the assays. Three VZV-susceptible donors were tested, and all demonstrated an in vitro response to multiple VZV peptides. This assay has potential as a screen to establish the immunogenicity of viral antigens in vitro using T cells from naive donors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9852971     DOI: 10.1086/514258

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  2 in total

1.  Phenotypic and functional characteristics of dendritic cells derived from human peripheral blood monocytes.

Authors:  Ling-ling Tang; Zhe Zhang; Jie-sheng Zheng; Ji-fang Sheng; Ke-zhou Liu
Journal:  J Zhejiang Univ Sci B       Date:  2005-12       Impact factor: 3.066

2.  Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus.

Authors:  J G Smith; X Liu; R M Kaufhold; J Clair; M J Caulfield
Journal:  Clin Diagn Lab Immunol       Date:  2001-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.